Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “labelling”
Effects of Open-label Placebos on COVID-related Psychological Health
ClinicalTrials.gov study NCT05035550. IPD Sharing: YES. Countries: 1. Publications: 0.
Open Label Study Evaluating the Efficacy and Safety of JUVÉDERM VOLUMA™ XC for the Facial Temporal Regions
ClinicalTrials.gov study NCT02437903. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT02406742. IPD Sharing: Not stated. Countries: 5. Publications: 0.
The Multicenter, Open-label, Single-use Autoinjector Convenience Study
ClinicalTrials.gov study NCT00958009. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY
ClinicalTrials.gov study NCT02665221. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Co
ClinicalTrials.gov study NCT00002118. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders
ClinicalTrials.gov study NCT00846547. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis
ClinicalTrials.gov study NCT00635089. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
ClinicalTrials.gov study NCT05536297. IPD Sharing: YES. Countries: 17. Publications: 0.
Long-term Open-Label Safety Study to Evaluate EN3409
ClinicalTrials.gov study NCT01755546. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER for the Treatment of Cluster Headaches.
ClinicalTrials.gov study NCT00203242. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates
ClinicalTrials.gov study NCT06686628. IPD Sharing: YES. Countries: 1. Publications: 0.
A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)
ClinicalTrials.gov study NCT00427362. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions
ClinicalTrials.gov study NCT02421679. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
ClinicalTrials.gov study NCT03624010. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Label, Multicenter, Phase II Study of Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases
ClinicalTrials.gov study NCT04339829. IPD Sharing: Not stated. Countries: 0. Publications: 13.
An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
ClinicalTrials.gov study NCT05369832. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
ClinicalTrials.gov study NCT02954887. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Open Label Pilot Study of Perampanel for the Treatment of Alcohol Use Disorder
ClinicalTrials.gov study NCT04502589. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
ClinicalTrials.gov study NCT02845674. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.